- Home
- XGN vs BCG Comparison
XGN vs BCG Comparison
Compare XGN & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XGN | BCG |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | United States | United States |
| Employees | N/A | 150 |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 32.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | XGN | BCG |
|---|---|---|
| Price | $3.49 | $1.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $8.86 | N/A |
| AVG Volume (30 Days) | ★ 400.4K | 91.0K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $13.00 | N/A |
| P/E Ratio | ★ N/A | $56.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $1.36 |
| 52 Week High | $12.23 | $3.44 |
Technical Indicators
Market Signals| Indicator | XGN | BCG |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 43.01 |
| Support Level | $3.15 | $1.46 |
| Resistance Level | $3.89 | $1.90 |
| Average True Range (ATR) | 0.28 | 0.18 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 56.95 | 8.82 |
Price Performance
Historical ComparisonAbout XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
About BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.